Akshay Atri - Biofil Chemicals Marketing Manager
| BIOFILCHEM | 44.25 1.70 3.70% |
Executive
Akshay Atri is Marketing Manager of Biofil Chemicals Pharmaceuticals
| Age | 33 |
| Address | 11/12, Sector 'E', Indore, India, 452015 |
| Phone | 91 73 1272 3016 |
| Web | https://www.biofilgroup.net |
Biofil Chemicals Management Efficiency
The company has return on total asset (ROA) of 0.0144 % which means that it generated a profit of $0.0144 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.04 %, meaning that it generated $0.04 on every $100 dollars invested by stockholders. Biofil Chemicals' management efficiency ratios could be used to measure how well Biofil Chemicals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Biofil Chemicals' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 480.1 K, whereas Other Current Assets are forecasted to decline to about 5.4 M.Biofil Chemicals Pharmaceuticals has accumulated 4.39 M in total debt. Debt can assist Biofil Chemicals until it has trouble settling it off, either with new capital or with free cash flow. So, Biofil Chemicals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biofil Chemicals Pha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biofil to invest in growth at high rates of return. When we think about Biofil Chemicals' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Zeal Rupani | Procter Gamble Health | N/A | |
| Sunil Punjabi | Procter Gamble Health | N/A | |
| Rajesh Khadatare | General Insurance | N/A | |
| Prachi Vichare | Procter Gamble Health | N/A | |
| Alagarsamy | General Insurance | N/A | |
| Shreyans Bachhawat | Home First Finance | N/A | |
| Balkrishna Variar | General Insurance | N/A | |
| Sumanta Ray | Global Health Limited | 53 | |
| Deepak Khanna | Global Health Limited | N/A | |
| Ajay Khetan | Home First Finance | N/A | |
| Radhika Ravishekar | General Insurance | N/A | |
| Bhuvander Kaul | Global Health Limited | N/A | |
| Manish Kayal | Home First Finance | N/A | |
| Sanjay Mokashi | General Insurance | N/A | |
| Saurabh Upadhyay | Global Health Limited | N/A | |
| Devendra Mani | Home First Finance | N/A | |
| Ramakrishna Vyamajala | Home First Finance | N/A | |
| M Balaji | Kavveri Telecom Products | 62 | |
| Rajesh Laheri | General Insurance | N/A | |
| Priya Arwat | Kavveri Telecom Products | N/A | |
| Sanjeev Kumar | Global Health Limited | N/A | |
Management Performance
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0144 |
Biofil Chemicals Pha Leadership Team
Elected by the shareholders, the Biofil Chemicals' board of directors comprises two types of representatives: Biofil Chemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biofil. The board's role is to monitor Biofil Chemicals' management team and ensure that shareholders' interests are well served. Biofil Chemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biofil Chemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pavan Rajput, Chief Officer | ||
| Anisha Mangal, Company Secretary | ||
| Joseph Chacko, Head Administration | ||
| Akshay Atri, Marketing Manager | ||
| Shweta Verma, Company officer | ||
| Vinayak Bhopte, Chief Chemist | ||
| Shikha Khilwani, Company Officer | ||
| Pawan Rajput, Chief Officer | ||
| Ketan Shah, COO Director | ||
| Ramesh Shah, CEO Chairman |
Biofil Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biofil Chemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0144 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 730.11 M | ||||
| Shares Outstanding | 16.27 M | ||||
| Shares Owned By Insiders | 59.77 % | ||||
| Price To Book | 3.91 X | ||||
| Price To Sales | 1.79 X | ||||
| Revenue | 400.35 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.